Effects of Intensive Systolic Blood Pressure Control on Glycometabolic and Cardiovascular Outcomes in Normoglycemic Patients: A Secondary Analysis of a Randomized Trial
Saved in:
| Main Authors: | Cheng Yang, Wei‐Hua Chen, Jie Qian, Rong‐Chong Huang, Jian‐Jun Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | MedComm |
| Online Access: | https://doi.org/10.1002/mco2.70197 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Invasively Measured Aortic Systolic Blood Pressure and Office Systolic Blood Pressure in Cardiovascular Risk Assessment in CKD
by: Christian D. Peters, et al.
Published: (2024-02-01) -
Annual Cost of Implementing Intensive Systolic Blood Pressure Goals in the United States
by: Jordan B. King, et al.
Published: (2024-09-01) -
Microfluidic Determination of Cell-Derived ATP and Single Cell Pressure Mapping Confirms Benefits of Normoglycemic Stored Red Blood Cells
by: Stephen A. Branch, et al.
Published: (2025-07-01) -
Association of Systolic Blood Pressure Time in Target Range With Cardiovascular Events Among PRECISION Participants
by: Neel Agarwal, et al.
Published: (2025-07-01) -
High Systolic Blood Pressure: focus on arterial elasticity
by: Zh. D. Kobalava, et al.
Published: (2006-12-01)